rs10845858

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000609686.4(GRIN2B):​c.-18-26558C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 152,226 control chromosomes in the GnomAD database, including 1,591 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1591 hom., cov: 32)

Consequence

GRIN2B
ENST00000609686.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.172

Publications

5 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000609686.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.-18-26558C>T
intron
N/ANP_000825.2
GRIN2B
NM_001413992.1
c.-18-26558C>T
intron
N/ANP_001400921.1
GRIN2B
NM_001413993.1
c.-18-26558C>T
intron
N/ANP_001400922.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.-18-26558C>T
intron
N/AENSP00000477455.1
GRIN2B
ENST00000630791.3
TSL:5
c.-18-26558C>T
intron
N/AENSP00000486677.3
GRIN2B
ENST00000627535.2
TSL:5
c.-18-26558C>T
intron
N/AENSP00000486411.1

Frequencies

GnomAD3 genomes
AF:
0.109
AC:
16624
AN:
152108
Hom.:
1592
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0302
Gnomad AMI
AF:
0.117
Gnomad AMR
AF:
0.253
Gnomad ASJ
AF:
0.125
Gnomad EAS
AF:
0.430
Gnomad SAS
AF:
0.178
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.137
Gnomad NFE
AF:
0.0937
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.109
AC:
16625
AN:
152226
Hom.:
1591
Cov.:
32
AF XY:
0.115
AC XY:
8585
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0302
AC:
1255
AN:
41558
American (AMR)
AF:
0.253
AC:
3867
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
435
AN:
3472
East Asian (EAS)
AF:
0.429
AC:
2216
AN:
5160
South Asian (SAS)
AF:
0.177
AC:
852
AN:
4822
European-Finnish (FIN)
AF:
0.114
AC:
1205
AN:
10590
Middle Eastern (MID)
AF:
0.127
AC:
37
AN:
292
European-Non Finnish (NFE)
AF:
0.0937
AC:
6373
AN:
68020
Other (OTH)
AF:
0.132
AC:
278
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
686
1372
2059
2745
3431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0689
Hom.:
178
Bravo
AF:
0.121
Asia WGS
AF:
0.266
AC:
925
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.7
DANN
Benign
0.53
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10845858; hg19: chr12-14045718; API